AsCNP/JSNP/JSCNP 2019

セッション情報

[AsCNP] ポスター発表

AsCNP » [AsCNP] ポスター発表

[AsCNP_P4] ポスター4
Bipolar Disorders 1

2019年10月11日(金) 13:40 〜 15:10 ポスター会場 (多目的ホール)

Chair: ‌Po See CHEN (Department of Psychiatry, College of Medicine, National Cheng Kung University, Taiwan)

13:40 〜 13:45

Takahiro MASUDA1, Tadafumi KATO2, Jun ISHIGOOKA3, Kei WATABE1, Mari MIYAJIMA1, Teruhiko HIGUCHI4, 5 (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. RIKEN Brain Science Institute, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

13:45 〜 13:50

Takahiro MASUDA1, Jun ISHIGOOKA2, Tadafumi KATO3, Kei WATABE1, Mari MIYAJIMA1, Teruhiko HIGUCHI4, 5 (1. Sumitomo Dainippon Pharma Co., Ltd., Japan, 2. Institute of CNS Pharmacology, Japan, 3. RIKEN Brain Science Institute, Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

13:50 〜 13:55

Jun ISHIGOOKA1, Tadafumi KATO2, Mari MIYAJIMA3, Kei WATABE3, Takahiro MASUDA3, Teruhiko HIGUCHI4, 5 (1. Institute of CNS Pharmacology, Japan, 2. RIKEN Brain Science Institute, Japan, 3. Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Japan Depression Center, Japan, 5. The National Center of Neurology and Psychiatry, Japan)

14:05 〜 14:10

Kunihiro IWAMOTO1, Akiko YAMAGUCHI1, Masahiko ANDO2, Kiyoshi FUJITA3, Motonori YOKOYAMA4, Tsuyoshi AKIYAMA5, Yoshio IGARASHI6, Reiji YOSHIMURA7, Norio OZAKI1 (1. Department of Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan, 2. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Aichi, Japan, 3. Department of Psychiatry, Okehazama Hospital, Aichi, Japan, 4. Sapporo Ekimae Clinic, Sapporo, Japan, 5. Department of Psychiatry, NTT Medical Center Tokyo, Tokyo, Japan, 6. Medical Care Toranomon, Tokyo, Japan, 7. Department of Psychiatry, University of Occupational and Environmental Health, Fukuoka, Japan)

14:10 〜 14:15

Fumitaka NAKANO1, Kyosuke UNO2, 3, Kazuki TOKORO2, Hiroki TAKEMOTO1, Atsumi NITTA1, 2 (1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 2. Department of Pharmaceutical Therapy and Neuropharmacology, Graduate School of Medicine and Pharmaceutical Science, University of Toyama, Toyama, Japan, 3. Laboratory of molecular pharmacology faculty of pharmaceutical sciences, University of Setsunan, Osaka, Japan)

14:15 〜 14:20

Cynthia SIU1, Mary Miu Yee WAYE2, Shitao RAO2, 3, 4, Marco Ho Bun LAM4, Ji-hui ZHANG4, Stephen Kwok Wing TSUI3, Yun Kwok WING4 (1. COS and Associates Ltd., Hong Kong SAR, China, 2. The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China, 3. School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China, 4. Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China)